Clorox Co (NYSE:CLX) Shares Sold by Murphy Capital Management Inc.

Share on StockTwits

Murphy Capital Management Inc. decreased its stake in shares of Clorox Co (NYSE:CLX) by 1.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,948 shares of the company’s stock after selling 75 shares during the period. Murphy Capital Management Inc.’s holdings in Clorox were worth $903,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CLX. First Trust Advisors LP raised its holdings in Clorox by 45.5% during the first quarter. First Trust Advisors LP now owns 315,484 shares of the company’s stock valued at $50,623,000 after acquiring an additional 98,676 shares during the period. Federated Investors Inc. PA raised its holdings in Clorox by 2,391.5% during the first quarter. Federated Investors Inc. PA now owns 38,295 shares of the company’s stock valued at $6,144,000 after acquiring an additional 36,758 shares during the period. The Manufacturers Life Insurance Company raised its holdings in Clorox by 11.6% during the first quarter. The Manufacturers Life Insurance Company now owns 135,483 shares of the company’s stock valued at $21,739,000 after acquiring an additional 14,045 shares during the period. Andra AP fonden bought a new stake in Clorox during the first quarter valued at about $6,370,000. Finally, Fort L.P. grew its position in shares of Clorox by 35.0% during the first quarter. Fort L.P. now owns 15,375 shares of the company’s stock valued at $2,467,000 after purchasing an additional 3,988 shares in the last quarter. 78.18% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have recently weighed in on CLX. Credit Suisse Group cut their price objective on Clorox from $172.00 to $168.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. JPMorgan Chase & Co. restated an “underweight” rating and set a $137.00 price objective (down previously from $143.00) on shares of Clorox in a research report on Thursday, October 3rd. Deutsche Bank cut their price objective on Clorox from $151.00 to $145.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Royal Bank of Canada raised their price objective on Clorox to $161.00 and gave the company a “sector perform” rating in a research report on Friday, August 2nd. Finally, Bank of America cut their price objective on Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. Clorox presently has a consensus rating of “Hold” and an average target price of $152.25.

In related news, Director A D. David Mackay sold 3,400 shares of Clorox stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total value of $526,558.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Michael R. Costello sold 6,997 shares of Clorox stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $162.56, for a total value of $1,137,432.32. Following the completion of the transaction, the senior vice president now owns 29,016 shares of the company’s stock, valued at approximately $4,716,840.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,609 shares of company stock valued at $2,497,443. 1.14% of the stock is currently owned by company insiders.

CLX opened at $150.25 on Friday. The firm has a market cap of $18.83 billion, a P/E ratio of 23.77, a P/E/G ratio of 5.06 and a beta of 0.40. Clorox Co has a 12 month low of $142.00 and a 12 month high of $167.70. The company has a current ratio of 0.91, a quick ratio of 0.55 and a debt-to-equity ratio of 4.09. The stock has a 50-day moving average of $155.25 and a 200 day moving average of $155.35.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The firm’s revenue was down 3.8% on a year-over-year basis. During the same quarter last year, the business posted $1.66 earnings per share. On average, research analysts forecast that Clorox Co will post 6.14 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 30th will be given a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, October 29th. This represents a $4.24 annualized dividend and a yield of 2.82%. Clorox’s dividend payout ratio is currently 67.09%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What are the risks of holding treasury bonds?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.